KMTS: the cashflow

MyFinsight

For the quarter ending 2025-10-31, KMTS had -$25,790K decrease in cash & cash equivalents over the period. -$25,608K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-10-31	2025-07-31
Net loss	-32,785	-25,826
Depreciation and amortization	2,373	2,028
Loss on disposal of property and equipment	-280	-280
Reserve for lost medical supplies	-	412
Reserve for lost equipment and supplies	901	-
Provision for uncollectible accounts receivable	537	613
Amortization of debt discounts and issuance costs	468	469
Share-based compensation expense	8,653	4,579
Non-cash lease expense	87	61
Change in fair value of warrant liabilities	844	-2,909
Disposable medical equipment supplies	-136	-460
Prepaid expenses and other current assets	-813	-140
Accounts receivable	1,705	1,777
Accounts payable	524	-2,896
Accrued liabilities	1,380	-860
Operating lease liabilities	-175	-138
Other long-term assets	-10	-10
Net cash used in operating activities	-18,343	-26,274
Purchases of property and equipment	7,265	8,166
Deposits for medical rental equipment	235	103
Refund of deposits for medical rental equipment	80	37
Net cash used in investing activities	-7,420	-8,232
Payments of ipo offering costs	-	1,875
Payment of equity issuance costs	1,902	-
Net cash provided by (used in) financing activities	-27	-1,875
Net increase (decrease) in cash, cash equivalents and restricted cash	-25,790	-36,381
Cash and cash equivalents at beginning of period	237,929	-
Cash and cash equivalents at end of period	175,758	-

Unit: Thousand (K) dollars